United States Cancer Biomarkers Market

The cancer biomarkers market in the United States is experiencing robust growth, driven by a myriad of factors that collectively underscore its significance in the field of oncology. Firstly, advancements in genomic and proteomic technologies have catalyzed the identification of novel biomarkers, expanding the repertoire of diagnostic and prognostic tools.

https://www.imarcgroup.com...